Organization: Novartis AG

QLT exploring asset sale to boost shareholder value

QLT Inc — once one of Canada’s most highly valued technology companies — has established a special committee to explore options for selling some or all of its assets. The move follows declining sales of its lead products for age-related macular degeneration and prostate cancer combined with delays in bringing other products to market. The…